Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Clinical Lymphoma, Myeloma & Leukemia|April 5, 2021
Mortality from Multiple Myeloma Within One Year Following Autologous Stem Cell Transplantation: Defining an Ultra-high Risk PopulationHannah M Cherniawsky, Hatem AlAhwal, Yasser Abou Mourad, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 4, 2019
Outpatient Autologous Stem Cell Transplants for Multiple Myeloma: Analysis of Safety and Outcomes in a Tertiary Care CenterShruthi Ganeshappa Kodad, Heather Sutherland, Wasithep Limvorapitak, et al.
Acta Haematologica|August 28, 2024
Real-World Impact of Routine Addition of Antithymocyte Globulin to Standard GVHD Prophylaxis in Myeloablative Unrelated Donor Transplants: Important Gains in Graft-versus-Host Disease Prevention though No Difference in Overall SurvivalNi Bai, Wasithep Limvorapitak, Robert Henderson, et al.
Cytotherapy|May 31, 2024
Outcomes with allogeneic stem cell transplant using cryopreserved versus fresh hematopoietic progenitor cell productsBo Angela Wan, Lorenzo Lindo, Yasser Abou Mourad, et al.
Leukemia & Lymphoma|February 11, 2022
Real-world treatment patterns and clinical outcomes in patients with AML unfit for first-line intensive chemotherapyToshihiro Miyamoto, David Sanford, Ciprian Tomuleasa, et al.
ACS Nano|November 26, 2013
Custom cerium oxide nanoparticles protect against a free radical mediated autoimmune degenerative disease in the brainKarin L Heckman, William DeCoteau, Ana Estevez, et al.
European Journal of Haematology|March 17, 2022
Healthcare resource utilization trends in patients with acute myeloid leukemia ineligible for intensive chemotherapy receiving first-line systemic treatment or best supportive care: A multicenter international studyTomoki Ito, David Sanford, Ciprian Tomuleasa, et al.
Blood Neoplasia|March 9, 2026
Heterogeneous survival outcomes in molecularly defined acute myeloid leukemia with myelodysplasia-related changesNicholas Chornenki, Afraa Fadul, Analiza Supan, et al.
Stem Cell Reviews and Reports|June 5, 2025
Outcomes Following Second Allogeneic Stem Cell Transplant for Graft Failure or Poor Graft Function: A Single Centre ExperienceJowon L Kim, Moss A Bruton Joe, Shanee Chung, et al.
Blood Cell Therapy|September 10, 2025
Racial Disparity in Myeloablative Hematopoietic Cell Transplantation Outcomes in Patients with Hematological Malignancies Older Than 45 YearsSatarupa Mohapatra, Yasser R Abou Mourad, Hannah M Cherniawsky, et al.
Pageof 4